Waters Corp
Change company Symbol lookup
Select an option...
WAT Waters Corp
BHR Braemar Hotels & Resorts Inc
NBSTU Newbury Street Acquisition Corp
SKX Skechers USA Inc
IGICW International General Insurance Holdings Equity Warrants 17th March 2025 *W EXP 03/17/2025
NHIC Newhold Investment II Corp
MMI Marcus & Millichap Inc
PEN Penumbra Inc
IGIC International General Insurance Holdings Ltd
Z Zillow Group Inc
Go

Health Care : Life Sciences Tools & Services | Mid Cap Blend
Company profile

Waters Corporation is a specialty measurement company that primarily designs, manufactures, sells and services high performance liquid chromatography (HPLC) ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company’s segments include Waters and TA. The Waters operating segment is designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instruments, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA operating segment designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments. The Company's LC and LC-MS instruments are utilized in a range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify compounds.

Closing Price
$329.44
Day's Change
-0.80 (-0.24%)
Bid
--
Ask
--
B/A Size
--
Day's High
335.08
Day's Low
327.18
Volume
(Light)
Volume:
375,221

10-day average volume:
473,524
375,221

Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab

8:12 am ET May 5, 2022 (BusinessWire) Print

Waters Corporation (NYSE: WAT) and The University of Delaware announced the grand opening of Immerse(TM) Delaware, a new Waters innovation and research laboratory. As part of their multi-year research partnership announced in October 2021, the lab opening is the first step on a journey to collaborate with biopharma scientists both in industry and academia to advance industrial processes for making and characterizing biotherapeutics.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220505005202/en/

Located at the University of Delaware Science, Technology and Advanced Research (STAR) campus, Immerse Delaware is a fully functional, fit-for-purpose, bioprocess laboratory enabling a dedicated focus on the entire manufacturing process from clone selection to quality control (QC) of drug substances. It will give students, faculty and industry researchers access to use and evaluate state-of-the-art analytical technologies from Waters as well as novel analytics, consumables and software that will enable the next generation of biotherapeutics.

"Our mission to address some of the biggest challenges in the development and manufacturing of biotherapeutics requires an immense amount of work, collaboration, and diversity of thought. Immerse Delaware will enable us to tap into an ecosystem of talent and expertise in biological manufacturing, coupled with Waters' experience in analytical technologies, to advance and accelerate the delivery of high-quality medicines to patients," said Dr. Udit Batra, President and CEO of Waters Corporation.

"As a research institution, the University of Delaware has a long history of advancing new discoveries and innovations that make our world safer, healthier and more vibrant," said UD President Dennis Assanis. "Today, the Immerse Delaware partnership with Waters Corp. is another exciting opportunity to extend our research impact and continue building on our successes in educating the next generation of leaders in the field of biopharmaceutical manufacturing."

Waters selected University of Delaware as a partner due to its leadership in chemical and biological manufacturing research as well its active support of and close proximity to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a collaborative effort amongst industry, academia, and regulators.

Notable attendees at the lab opening included: Dennis Assanis, PhD, President, University of Delaware; Udit Batra, PhD, President and CEO, Waters Corporation; Chai Gadde, CEO of BioTek reMEDys; Kelvin Lee, PhD, Director, NIIMBL and Gore Professor of Biomolecular Engineering; Levi Thompson, PhD, Dean, College of Engineering, University of Delaware; and Michael Flemming, President, Delaware Biosciences.

Additional Resources

Learn more about Immerse Delaware, a Waters Innovation & Research Lab Learn more about the University of Delaware's STAR Campus Connect with Waters via Twitter, Facebook and LinkedIn

About the University of Delaware (www.udel.edu)

The University of Delaware, located in Newark, Delaware, traces its beginnings to a small private academy established in 1743. Today, UD is a research-intensive, technologically advanced institution offering more than 150 academic majors across nine colleges, serving more than 23,000 undergraduate and graduate students. The University's distinguished faculty includes internationally renowned authors, scientists and artists. The Carnegie Foundation for the Advancement of Teaching has classified UD as having very high research activity--a designation accorded fewer than 3% of U.S. colleges and universities. The University's Science, Technology and Advanced Research (STAR) Campus in Newark is a growing center for innovation, blending cutting-edge research, top-notch academics and thriving businesses in one location. Delaware has 21 varsity sports teams that compete at the Division 1 level in the Colonial Athletic Association and the Football Championship Subdivision.

About Waters Corporation (www.waters.com)

Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,800 employees worldwide, Waters operates directly in more than 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.

Waters and Immerse are trademarks of Waters Corporation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220505005202/en/

SOURCE: Waters Corporation">

Andrea Boyle Tippet
Senior Director, External Relations
University of Delaware
aboyle@udel.edu

Kevin Kempskie
Senior Director, Public Relations
Waters Corporation
pr@waters.com
comtex tracking

COMTEX_406737029/1006/2022-05-05T08:12:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.